Polycystic Ovarian Syndrome (PCOS) Therapeutics Market

Polycystic Ovarian Syndrome (PCOS) Therapeutics
Market to Grow due to Rising Occurrence of
Diabetes and Obesity Globally
A new market research report by Transparency Market Research, titled “Polycystic Ovarian
Syndrome (PCOS) Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends
and Forecast, 2013 - 2019”, presents an extensive evaluation of this market both in terms of
volume and revenue. The competition within the market has been assessed by employing the
Porter’s five forces model. The study also presents an in-depth analysis of the governing factors,
macro-economic indicators, and the prevailing market trends. The market attractiveness of all
segments within the market for PCOS therapeutics has also been presented.
Polycystic ovarian syndrome (PCOS) is a type of endocrine system disorder common amongst
females between the age of 18 and 44 years. PCOS comprises a set of symptoms caused owing to
the elevated male hormone testosterone within women. Symptoms and signs of PCOS comprise
heavy, irregular, or no menstruation; excess hair on body or face; acne; pelvic pain; difficulty in
conceiving; velvety skin, among others. PCOS can be caused owing to a number of
environmental and genetic factors. The market for PCOS therapeutics is segmented into
contraceptive drugs, anti-androgen drugs, ovulation stimulants, diabetes treatment drugs, dietary
supplements, and cancer treatment drugs.
According to the report, the market for PCOS therapeutics is growing owing to a number of
factors. Some of the major factors driving the growth of the market include the rising occurrence
of diabetes, the rising hormonal and genetic disorders, and the increasing obese population.
Amongst these, PCOS is most common in obese and diabetic women. Furthermore, the
increasing count of drugs in clinical trials and their expected commercialization in the coming
years will also propel the growth of the market, as per this study.
On the other hand, the increasing penetration of generic and off-label drugs in PCOS therapeutics
may inhibit the development of the market. However, the failure of off-label drugs to show the
desired results has led to an increased demand for branded drugs for the treatment of PCOS, thus
bringing new opportunities for the growth of the market.

In terms of geography, the report segments the market into Europe, North America, Asia Pacific,
and Rest of the World (RoW). Amongst these, North America leads the market for PCOS
therapeutics and is trailed by Europe. This is owing to the soaring count of women having PCOS
within this region resulting in increased diagnosis. On the other hand, Asia Pacific is predicted to
exhibit the greatest growth rate in the market for PCOS therapeutics owing to the improving
economic conditions and the growing awareness about gynecological healthcare here.
About Us
Transparency Market Research (TMR) is a global market intelligence company providing
business information reports and services. The company’s exclusive blend of quantitative
forecasting and trend analysis provides forward-looking insight for thousands of decision
makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data
sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that
it always reflects the latest trends and information. With extensive research and analysis
capabilities, Transparency Market Research employs rigorous primary and secondary research
techniques to develop distinctive data sets and research material for business reports.
Contact Us
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com